Fr. 70.00

Annals of Life Insurance Medicine - 1964 Volume II

Inglese · Tascabile

Spedizione di solito entro 6 a 7 settimane

Descrizione

Ulteriori informazioni

One thousand unselected patients with bronchial asthma have been followed up for an average period of 11 years, with extremes of 33 years and three years. The average period from the first symptoms to the date of follow-up was 20.6 years in the 562 males and 22.3 years in the 438 females, with extremes of 72 years and three years. Since throughout the analysis no differences were found between the sexes, they have been grouped together. Terms used, such as asthma, chronic bronchitis, childhood bronchitis, age of onset, etc., have been carefully defined, as have the descriptions of intermittent and continuous asthma. The present state of the patients has been classified as A (good), B (fair), C (poor), and D (dead). Early age of onset (before 16) and intermittent asthma were associated and had a more favourable prognosis, while the childhood bronchitic had a better outlook than the adult bronchitic. Intermittent and continuous asthma have been compared. The incidence of bronchitis initially was higher in the continuous group, and the tendency to develop bronchitis over the years (present in all asthmatics) was also greater in the continuous group. Those with bronchitis were in much poorer health on follow-up than those without.

Sommario

Extra Mortality and Expectation of Life.- Maximum Utilization of the Life Table Method in Analyzing Survival.- The Underwriting of Blood Pressure Abnormalities.- The Prognosis of Chronic Nephritis.- A Survey of Heart Disease in Africa, with Particular Attention to Southern Africa.- Electrocardiographic and Pathologic Features of Myocardial Infarction in Man.- Estudio Epidemiologico de la Hipertension Arterial y de la Isquemia Miocardica.- An Epidemiological Study of Hypertension and Myocardial Ischaemia.- Anti Hypertensive Therapy and Its Effect on Risk Evaluation.- Aglycosuric Diabetes.- Changing Concepts in Vascular Surgery.- Asthma: A Study in Prognosis of 1,000 Patients.- Choice and Limitations of the Various Operations for the Surgical Treatment of Lung Cancer.- Author index.

Riassunto

One thousand unselected patients with bronchial asthma have been followed up for an average period of 11 years, with extremes of 33 years and three years. The average period from the first symptoms to the date of follow-up was 20.6 years in the 562 males and 22.3 years in the 438 females, with extremes of 72 years and three years. Since throughout the analysis no differences were found between the sexes, they have been grouped together. Terms used, such as asthma, chronic bronchitis, childhood bronchitis, age of onset, etc., have been carefully defined, as have the descriptions of intermittent and continuous asthma. The present state of the patients has been classified as A (good), B (fair), C (poor), and D (dead). Early age of onset (before 16) and intermittent asthma were associated and had a more favourable prognosis, while the childhood bronchitic had a better outlook than the adult bronchitic. Intermittent and continuous asthma have been compared. The incidence of bronchitis initially was higher in the continuous group, and the tendency to develop bronchitis over the years (present in all asthmatics) was also greater in the continuous group. Those with bronchitis were in much poorer health on follow-up than those without.

Dettagli sul prodotto

Con la collaborazione di Swis Reinsurance Company (Editore), Swiss Reinsurance Company (Editore), Swiss Reinsurance Company (Editore), Swiss Reinsurance Company (Editore)
Editore Springer, Berlin
 
Lingue Inglese
Formato Tascabile
Pubblicazione 26.05.2014
 
EAN 9783642856167
ISBN 978-3-642-85616-7
Pagine 218
Dimensioni 178 mm x 12 mm x 254 mm
Peso 434 g
Illustrazioni IV, 218 p. 130 illus., 4 illus. in color.
Categorie Scienze naturali, medicina, informatica, tecnica > Medicina > Tematiche generali

C, Medicine, Surgery, Heart, Therapy, Health, childhood, patients, Health Sciences, Medicine/Public Health, general, Mortality

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.